Dr. Mark Daniel Bouchard
MD | Pediatrics | Male
Dr. Mark Daniel Bouchard, MD is a Issaquah, Washington based Pediatric doctor with medical specialization in
General Pediatrics.
Current practice location of Dr. Mark Daniel Bouchard is
751 Ne Blakely Dr Ste 5010, Issaquah, Washington - 98029-6201. He can be contacted on phone at
425-394-0700 and fax number 425-394-0757.
Dr. Mark Daniel Bouchard is a sole proprietor of his business.
NPI number (Unique professional ID) for Dr. Mark Daniel Bouchard is
1316392517 which was assigned by NPPES on 26 Apr, 2016 and it was last updated on 17 Jan, 2022.
Dr. Mark Daniel Bouchard license number is
MD61046264 for Pediatrics (208000000X) in Washington.
Dr. Mark Daniel Bouchard is a pediatrician who is concerned with the physical, emotional and social health of children from birth to young adulthood. Care encompasses a broad spectrum of health services ranging from preventive healthcare to the diagnosis and treatment of acute and chronic diseases. A pediatrician deals with biological, social and environmental influences on the developing child, and with the impact of disease and dysfunction on development.
Complete Profile:
Dr. Mark Daniel Bouchard basic information including his official name, gender, specialization, credentials etc. are as mentioned below.
Specialization : | Pediatrics |
---|
Provider Name : | Dr. Mark Daniel Bouchard |
---|
Credential : | MD |
---|
Gender : | Male |
---|
Business Address:
Dr. Mark Daniel Bouchard address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address : | 751 Ne Blakely Dr Ste 5010 Issaquah, WA, 98029-6201 United States |
---|
Phone Number : | 425-394-0700 |
---|
Fax Number : | 425-394-0757 |
---|
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : | 1316392517 |
---|
NPI Entity Type : | Individual |
---|
First Enrolment Date : | 26 Apr, 2016 |
---|
Last Updated On : | 17 Jan, 2022 |
---|
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Mark Daniel Bouchard are as mentioned. Primary taxonomy code for Dr. Mark Daniel Bouchard, MD is
208000000X (Pediatrics).
Taxonomy Code | Speciality | Primary | License No. | State |
---|
208000000X | Pediatrics | Yes | MD61046264 | WA |
Legacy Identifiers:
Other legacy medical identifiers of Dr. Mark Daniel Bouchard such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned below.
Identifier | Identifier Type | State | Issuer |
---|
1316392517 | MEDICAID | WA | |
Endpoints:
Endpoints provide a simple, secure, scalable, and standards-based way for participants to send authenticated, encrypted health information directly to known, trusted recipients over the Internet. It is used by EHR systems (Electronic Health Records).
Endpoint Type | Endpoint | Affiliation | Use | Content | Address |
---|
SOAP (SOAP URL) | https://careepicwa.kp.org:14430/Interconnect-CE-PRD/wcf/epic.community.hie/xcpdrespondinggatewaysync
Carequality | No affiliation | HIE Health Information Exchange (HIE)
| OTHER Other C-CDA | 201 16TH AVE E, SEATTLE, WA, 98112-5226 United States |
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address : | Po Box 25608 Salt Lake City, UT, 84125-0608 United States |
---|
Phone Number : | 206-320-4476 |
---|
Fax Number : | 206-568-7043 |
---|
Business Location:
Patients can refer following map for directions to
Dr. Mark Daniel Bouchard practice address. Don't forget to take prior appointment before visiting.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.